These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31659970)

  • 1. Myelofibrosis in Patients of Chronic Myeloid Leukemia in Chronic Phase at Presentation.
    Hamid A; Ashraf S; Qamar S; Naveed MA; Hameed A; Farooq MA
    J Coll Physicians Surg Pak; 2019 Nov; 29(11):1096-1100. PubMed ID: 31659970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grading of marrow fibrosis in chronic myeloid leukemia--a comprehensive approach.
    Rao S; Sen R; Singh S; Ghalaut PS; Arora BB
    Indian J Pathol Microbiol; 2005 Jul; 48(3):341-4. PubMed ID: 16761746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow trephine biopsy findings in chronic myeloid leukemia.
    Khonglah Y; Basu D; Dutta TK
    Malays J Pathol; 2002 Jun; 24(1):37-43. PubMed ID: 16329554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow core biopsy in 508 consecutive patients with chronic myeloid leukemia: Assessment of potential value.
    Hidalgo-Lόpez JE; Kanagal-Shamanna R; Quesada AE; Gong Z; Wang W; Hu S; Medeiros LJ; Bassett RL; d'Orcy E; Yin CC; Cortes J; Jabbour EJ; Kantarjian HM; Bueso-Ramos CE
    Cancer; 2018 Oct; 124(19):3849-3855. PubMed ID: 30321462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the volume ratio of bone marrow affected by fibrosis: a parameter crucial for the prognostic significance of marrow fibrosis in chronic myeloid leukemia.
    Buesche G; Georgii A; Duensing A; Schmeil A; Schlue J; Kreipe HH
    Hum Pathol; 2003 Apr; 34(4):391-401. PubMed ID: 12733122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.
    Xubo G; Xingguo L; Xianguo W; Rongzhen X; Xibin X; Lin W; Lei Z; Xiaohong Z; Genbo X; Xiaoying Z
    Eur J Haematol; 2009 Oct; 83(4):292-301. PubMed ID: 19500135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow features and clinical findings in chronic myeloid leukemia--a comparative, multicenter, immunohistological and morphometric study on 614 patients.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Zirbes TK; Birnbaum F; Kressmann C; Melguizo-Grahmann M; Frackenpohl H; Sprungmann C; Leder LD; Diehl V; Zankovich R; Schaefer HE; Niederle N; Fischer R
    Leuk Lymphoma; 2000 Jan; 36(3-4):295-308. PubMed ID: 10674901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of interferon versus busulfan therapy on the reticulin stain-measured fibrosis in CML--a comparative morphometric study on sequential trephine biopsies.
    Thiele J; Kvasnicka HM; Niederle N; Zirbes TK; Schmidt M; Dammasch J; Meuter BR; Leder LD; Kloke O; Diehl V
    Ann Hematol; 1995 Mar; 70(3):121-8. PubMed ID: 7536475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Incidence and nature of myelofibrosis in chronic myeloleukemia (based on trephine biopsy data)].
    Semenova EA; Khokhlova MP
    Gematol Transfuziol; 1988 Aug; 33(8):23-8. PubMed ID: 3192051
    [No Abstract]   [Full Text] [Related]  

  • 10. [Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha].
    Kumas Sotiris ; Semenova EA; Turkina AG; Zakharova AV; Domracheva EV; Khoroshko ND; Frank GA
    Arkh Patol; 2003; 65(4):9-12. PubMed ID: 14518186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathological characteristics of leukemia patients with secondary myelofibrosis and their relationship with the prognosis of disease].
    Guan JH; Wang XN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):311-4. PubMed ID: 23628022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up studies with sequential bone marrow biopsies in chronic myeloid leukaemia and so-called primary (idiopathic) osteo-myelofibrosis. Evolution of histopathological lesions and clinical course in 40 patients.
    Thiele J; Simon KG; Fischer R; Zankovich R
    Pathol Res Pract; 1988 Aug; 183(4):434-45. PubMed ID: 3186544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphometric analysis of myelofibrosis in agnogenic myeloid metaplasia and chronic myelogenous leukemia.
    Ohsaka A; Miura Y; Takahashi A; Yokoyama T
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(6):399-405. PubMed ID: 1683056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of megakaryocyte proliferation of the evolution of myelofibrosis. Histological follow-up study in 186 patients with chronic myeloid leukaemia.
    Buhr T; Choritz H; Georgii A
    Virchows Arch A Pathol Anat Histopathol; 1992; 420(6):473-8. PubMed ID: 1609507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment intensity significantly influencing fibrosis in bone marrow independently of the cytogenetic response: meta-analysis of the long-term results from two prospective controlled trials on chronic myeloid leukemia.
    Buesche G; Freund M; Hehlmann R; Georgii A; Ganser A; Hecker H; Heimpel H; Fonatsch C; Heinze B; Pfirrmann M; Holgado S; Schmeil A; Tobler A; Hasford J; Buhr T; Kreipe HH;
    Leukemia; 2004 Sep; 18(9):1460-7. PubMed ID: 15284854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and quantification of bone marrow fibrosis are significantly biased by the pre-staining processing of bone marrow biopsies.
    Buesche G; Georgii A; Kreipe HH
    Histopathology; 2006 Jan; 48(2):133-48. PubMed ID: 16405662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
    Thiele J; Kvasnicka HM; Beelen DW; Flucke U; Spoer C; Paperno S; Leder LD; Schaefer UW
    Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of interferon-alpha therapy on bone marrow fibrosis in chronic myelogenous leukemia.
    Wilhelm M; Bueso-Ramos C; O'Brien S; Pierce S; Keating M; Talpaz M; Kantarjian HM
    Leukemia; 1998 Jan; 12(1):65-70. PubMed ID: 9436922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Impact of Bone Marrow Fibrosis and Effects of Tyrosine Kinase Inhibitors on Bone Marrow Fibrosis in Chronic Myeloid Leukemia.
    Pepeler MS; Tıglıoglu M; Dagdas S; Ozhamamcıoglu E; Han U; Albayrak A; Aydın MS; Korkmaz G; Pamukcuoğlu M; Ceran F; Albayrak M; Ozet G
    Clin Lymphoma Myeloma Leuk; 2024 Apr; 24(4):e161-e167. PubMed ID: 38342726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance and dynamics of myelofibrosis regarding hematopoietic reconstitution after allogeneic bone marrow transplantation in chronic myelogenous leukemia--a single center experience on 160 patients.
    Thiele J; Kvasnicka HM; Beelen DW; Zirbes TK; Jung F; Reske D; Leder LD; Schaefer UW
    Bone Marrow Transplant; 2000 Aug; 26(3):275-81. PubMed ID: 10967565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.